[SAN FRANCISCO, USA – May 14^th, 2025] – The animal microbiome diagnostics market is projected to grow at a 24% CAGR, reaching $6.4B by 2031, according to a new 350-page ClearView report.

Request Sample @ https://clearviewmarketinsights.com/report-details/animal-microbiome-diagnostics-market/

Key drivers:

Industry Shifts

1. Regulatory Catalysts:
• EU bans feed-grade antibiotics (2024).
• China’s aquaculture microbiome funding ($200M).
2. Clinical Proof:
• AnimalBiome’s Test: Reduces canine diarrhea by 65%.
• DSM’s Tool: Boosts milk yield 12% (Cornell study).
3. Consumer Trends:
• 62% of pet owners prioritize gut health (Packaged Facts).
• "Microbiome-Certified" pet food sells at 2.5x premium.

Executive Quotes

• Holly Ganz, AnimalBiome CEO:
  "Gut health is the new wellness frontier—for pets and profits."
• Dr. Markus Wyss, DSM R&D Head:
  "Our tools cut antibiotics without sacrificing yield."

Future Projections

• 2026: First fecal transplant kits for pets ($149 MSRP).
• 2030: 60% of livestock farms use microbiome testing.

For more insights, visit https://clearviewmarketinsights.com/

About ClearView Market Insights Analytics

ClearView Market Insights Analytics is a global leader in industrial technology research, offering actionable insights across more than 100 laser market segments.

Media contact:

Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369